Atrium Biotechnologies Inc. today announced that it is changing its name to Atrium Innovations Inc. The name change reflects the evolution from being the subsidiary of a biotechnology company to a leading multi product manufacturer and marketer as well as the increased recognition for having a diversified and innovative product portfolio. This new name demonstrates a global perspective and facilitates the creation of shareholder value through a new and clearer image of an integrated international company.

Board of Directors

Mr. Pierre Laurin, Chairman of the Board of Atrium Innovations, announced the appointment of Mrs. Carole St-Charles to the Board of Atrium Innovations. Mrs. St-Charles is the president of Consortium J.L.F. Inc., a limited partner of J.L Freeman LP which commercializes food and O.T.C. health care products. "We are delighted to be able to count on her pertinent business experience to pursue our strategic plan", stated Pierre Laurin.